{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1429"}, "official-title": {"#tail": "\n\t", "#text": "To expand the research and awareness activities of the\n\t\t  National Institute of Arthritis and Musculoskeletal and Skin Diseases and the\n\t\t  Centers for Disease Control and Prevention with respect to scleroderma, and for\n\t\t  other purposes."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130409", "#text": "April 9, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t herself and ", "#text": "Mrs. Capps", "@name-id": "C001036"}, "cosponsor": {"#tail": ")\n\t\t\t introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Mr. King of New York", "@name-id": "K000210"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H090659FA429C4A8CAFAC53764E8F5CEB", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Scleroderma Research and Awareness Act\n\t\t\t of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HC356773184EA40C2ABAF64DD125FF496"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Part B of title IV of the Public Health\n\t\t\t Service Act", "@value": "Public Health Service Act/t:IV/pt:B"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 284 et seq.", "@value": "usc/42/284/etseq"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "National\n\t\t\t institute of arthritis and musculoskeletal and skin diseases; scleroderma\n\t\t\t research expansion"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tmay expand, intensify, and coordinate the activities of the ", "@entity-type": "federal-body", "#text": "Director of NIH", "@entity-id": "7529"}, {"#tail": " with respect to scleroderma, with particular emphasis on the\n\t\t\t\tfollowing:", "@entity-type": "federal-body", "#text": "National Institutes\n\t\t\t\tof Health", "@entity-id": "7529"}], "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n          ", "#text": "409K."}, "header": {"#tail": "\n          ", "#text": "Scleroderma\n\t\t\t\tresearch"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Research focused\n\t\t\t\ton the etiology of scleroderma and the development of new treatment\n\t\t\t\toptions."}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "@id": "H4EB4D1A0CAFF41DE92DAA0BD20ACC5C8", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Clinical research\n\t\t\t\tto evaluate new treatments options."}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "@id": "H575031166F6642049C01EDF3B6C46AE3", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7529"}, "#text": "Basic research on\n\t\t\t\tthe relationship between scleroderma and secondary conditions such as pulmonary\n\t\t\t\thypertension, gastroparesis, Raynaud's phenomenon, Sj\u00f6gren's Syndrome, and\n\t\t\t\tother diseases as determined by the\n\t\t\t\t"}, "enum": {"#tail": "\n            ", "#text": "(3)"}, "@id": "H6AF6D888F36247EFA89713367A424487", "#text": "\n            "}], "#text": "\n          ", "@id": "H25B130B434D34E3287B3706212359A29"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "HB22ED7A7578E4E9FBB7C254586E66CA0"}, "#text": "\n      ", "@id": "H471B6005B4FF4EC195BA3EB11775A10E"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is\n\t\t\t amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Part\n\t\t\t P of title III of the Public Health Service Act", "@value": "Public Health Service Act/t:III/pt:P"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 280g et seq.", "@value": "usc/42/280g/etseq"}, "@parsable-cite": "usc/42/280g", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Promoting public\n\t\t\t awareness of scleroderma"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may carry out an educational\n\t\t\t\tcampaign to increase public awareness of scleroderma. Print, video, and\n\t\t\t\tWeb-based materials distributed through this campaign may include\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n          ", "#text": "399V\u20136."}, "header": {"#tail": "\n          ", "#text": "Promoting\n\t\t\t\tpublic awareness of scleroderma"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "basic information\n\t\t\t\ton scleroderma and its symptoms; and"}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "@id": "H93DF976244AE40E78E9C7AB696E2AE9C", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "information\n\t\t\t\ton\u2014"}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "#text": "\n            ", "@id": "H29BC20035BB34BBC8EB894BB1874A7D6", "subparagraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the incidence and\n\t\t\t\tprevalence of scleroderma;"}, "enum": {"#tail": "\n              ", "#text": "(A)"}, "@id": "H1DD3B4BFBADA44E888EDEC404D63EA86", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "diseases and\n\t\t\t\tconditions affiliated with scleroderma; or"}, "enum": {"#tail": "\n              ", "#text": "(B)"}, "@id": "H1F8D2618130246009F4B1A16F8050A61", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the importance of\n\t\t\t\tearly diagnosis and treatment of\n\t\t\t\tscleroderma."}, "enum": {"#tail": "\n              ", "#text": "(C)"}, "@id": "HA2A7AC414C7E4F36A22662BE38E87170", "#text": "\n              "}]}], "#text": "\n          ", "@id": "H8E830345A8054D6E9673F2E7E5676E29"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H05CFAF51CC2940CC84959A6101AFB4EF"}, "#text": "\n      ", "@id": "H587120B818284F259EA669F834E67B8D"}], "#text": "\n\t\t", "@id": "HDD2F09916BF544F8B9172A25B02FC87E"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-04-09"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1429 IH: Scleroderma Research and Awareness Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}